MENU
BIVI
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
BioVie (BIVI) Ownership - Who owns BioVie?
BioVie Inc is a clinical-stage company developing drug therapies to treat chronic debilitating conditions including liver disease and neurological and neuro-degenerative disorders and certain cancers... Show more
Profile
Industry
N/A
Address
680 W Nye Lane
Phone
+1 775 888-3162
Employees
13
Web
https://www.bioviepharma.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
13.11M
P/E Ratio
N/A
Total Cash
17.54M
Projected Growth
N/A
Total Debt
349.89K
Revenue
N/A
Risk (Beta)
-0.73
Dividend Yield
N/A
Total Cash/Share
2.33
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
Fundamentals
BIVI
Capitalization
13.1M
P/E Ratio
N/A
Risk (Beta)
-0.73
Dividend Yield
N/A
Total Cash
17.5M
Total Cash/Share
2.33
Total Debt
350K
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
19M
P/B Ratio
0.69
Cash Flow
N/A
Earnings
-12.12
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
7.48K
Current Ratio
9.10
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
-16.98M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-76.59
Shares Held By Institutions
1.26M
Shares Outstanding - Current
7.53M
Total Liabilities
2.55M
Total Volume MTD
N/A
Value
1
Gain YTD
-91.300
View a ticker or compare two or three
VS
VS
Show more...
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period.
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
680 W Nye Lane
Phone
+1 775 888-3162
Employees
13
Web
https://www.bioviepharma.com